PrEP

A new CDC study suggests that only a small percentage of Americans who could potentially benefit from pre-exposure prophylaxis (PrEP), a daily pill for HIV prevention, have been prescribed it. In the first detailed analysis by race and by risk group, CDC researchers found while two-thirds of those who could potentially benefit from PrEP are African American or Latino, these … [Read more...] about PrEP not reaching those who could potentially benefit from it the most